a:1:{s:5:"en_US";s:23:"University of Catanzaro";}.
Department of Surgical and Medical Sciences, University of Catanzaro "Magna Graecia" Italy.
Acta Biomed. 2021 Jul 1;92(3):e2021237. doi: 10.23750/abm.v92i3.10952.
To determine the efficacy of the synergistic use of High Power Laser Therapy (HPLT) with glucosamine sulfate (GS) in knee osteoarthritis.
This 2-arm randomized controlled trial (RCT) enrolled 90 subjects (M=53, F=37, y= 55±11.2) and randomly allocated using a stratified sampling method in experimental group (A) with HPLT+GS 1500mg (GS - Dona®, Rottapharm, Monza, Italy) (n=45) or in a control group (B) with HPLT + placebo (n=45). Results: VAS score in Activities of day Living (ADL), Standardized stair climb test (SSCT), Zohlen's sign (RASPING) and Rabot test were used, to evaluate patients at the beginning of the study (T0), at 2 months (T1) and at 6 months (T2). In the mean scores for VAS in ADL, SSCT, RABOT and RASPING at T1, no significant differences were found between the experimental and the control group with paired T and ANOVA test. But significant differences between groups (p<0.05) in all outcomes were observed at 6 months (T2).
HPLT is useful in treating knee osteoarthritis, but when combined with Glucosamine Sulfate, thanks to the synergy of two interventions, can achieve a long-term effect up to 6 months after treatment.
评估高功率激光疗法(HPLT)与硫酸氨基葡萄糖(GS)协同治疗膝关节骨关节炎的疗效。
本研究采用双臂随机对照试验(RCT)纳入了 90 名受试者(M=53,F=37,y=55±11.2),并采用分层抽样法将其随机分配到实验组(A)(接受 HPLT+GS 1500mg[GS-Dona®, Rottapharm, Monza, Italy],n=45)或对照组(B)(接受 HPLT+安慰剂,n=45)。
采用视觉模拟评分(VAS)评估日常生活活动(ADL)、标准爬楼梯试验(SSCT)、Zohlen 征(RASPING)和 Rabot 试验,以评估患者在研究开始时(T0)、2 个月(T1)和 6 个月(T2)的情况。在 T1 时 ADL、SSCT、RABOT 和 RASPING 的 VAS 平均评分中,配对 T 检验和方差分析(ANOVA)未发现实验组和对照组之间存在显著差异。但在 6 个月(T2)时,两组在所有结果上均存在显著差异(p<0.05)。
HPLT 治疗膝关节骨关节炎有效,但与硫酸氨基葡萄糖联合使用时,由于两种干预措施的协同作用,可在治疗后长达 6 个月内获得长期效果。